explore -WSS

explore

author：focus 2025-10-02 21:05:53 - browse：128

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Leon Gautier, last member of French D

focus

WSS

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

EU climate chief is concerned over the expansion of the coal industry in China

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

10 states plan to sue EPA over standards for residential wood

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

focus

explore

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

Yancopoulos of Regeneron works to expand Dupixent success

What does generative AI mean for health care? We asked experts

Readout Newsletter: Illumina, CRISPR, Regeneron

Affirmative action in medical school literally saved lives

U.K. officials, researchers try to ease path for bespoke genetic treatments

Medicare details structure of new drug price negotiation program

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Bright Health sells Medicare Advantage business to Molina

Diabetes management: Digital health tools fall short, study says

leisure time

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

With Wegovy coverage, Medicare patients may face high costs

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

hotspot

explore

focus

entertainment